DJ Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ slid 1.72% to $805.02 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.52% to 7,623.68 and Dow Jones Industrial Average falling 1.23% to 52,215.16.
Regeneron Pharmaceuticals Inc. closed 6.32% below its 52-week high of $859.34, which the company reached on September 3rd.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Amgen Inc. $(AMGN)$ fell 1.79% to $439.26, Moderna Inc. (MRNA) fell 1.25% to $200.10, and Gilead Sciences Inc. (GILD) fell 0.73% to $156.04.
Trading volume (526,467) remained 164,833 below its 50-day average volume of 691,300.
Data source: Dow Jones Market Data, FactSet. Data compiled October 23, 2026.